Sleep Medicine
Volume 4, Issue 4 , Pages 275-280 , July 2003

Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists

  • Thomas Roth

      Affiliations

    • Henry Ford Hospital, Sleep Disorders and Research Center, Clara Ford Pavilion, 3rd Floor, 2799 West Grand Boulevard CFP-3, Detroit, MI 48202, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-313-916-4417; fax: +1-313-916-5167
    • ,
  • David B. Rye

      Affiliations

    • Emory University School of Medicine, Department of Neurology, Atlanta, GA, USA
    • ,
  • Leona D. Borchert

      Affiliations

    • Pharmacia Corporation, Bedminster, NJ, USA
    • ,
  • Cindy Bartlett

      Affiliations

    • Pharmacia Canada,Markham, Ont., Canada
    • ,
  • Donald L. Bliwise

      Affiliations

    • Emory University School of Medicine, Department of Neurology, Atlanta, GA, USA
    • ,
  • Charles Cantor

      Affiliations

    • University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    • ,
  • Jay M. Gorell

      Affiliations

    • Henry Ford Hospital, Sleep Disorders and Research Center, Clara Ford Pavilion, 3rd Floor, 2799 West Grand Boulevard CFP-3, Detroit, MI 48202, USA
    • ,
  • Jean P. Hubble

      Affiliations

    • The Ohio State University, Department of Neurology, Columbus, OH, USA
    • ,
  • Bruno Musch

      Affiliations

    • Pharmacia Corporation, Bedminster, NJ, USA
    • ,
  • C.Warren Olanow

      Affiliations

    • Mount Sinai School of Medicine, New York, NY, USA
    • ,
  • Charles Pollak

      Affiliations

    • The Ohio State University, Department of Neurology, Columbus, OH, USA
    • ,
  • Matt B. Stern

      Affiliations

    • University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    • ,
  • Ray L. Watts

      Affiliations

    • Emory University School of Medicine, Department of Neurology, Atlanta, GA, USA

Received 19 November 2002 ,Revised 11 February 2003 ,Accepted 14 February 2003.

References 

  1. Lees AJ, Blackburn NA, Campbell VL. The nighttime problems of Parkinson's disease. Clin Neuropharmacol. 1988;11:512–519
  2. Rye D, Bliwise D. Movement disorders specific to sleep and the nocturnal manifestations of waking movement disorders. In:  Watts R,  Koller W editor. Movement disorders: neurologic principles and practice. New York, NY: McGraw-Hill; 1997;p. 687–713
  3. Askenazy JJM, Yahr MD. Sleep in Parkinson's disease. Acta Neurol Scand. 1990;87:167–170
  4. Stocchi F, Barbato L, Nordera G, Berardelli A, et al.  Sleep disorders in Parkinson's disease. J Neurol. 1998;245(Suppl. 1):S15–S18
  5. Aldrick M. Parkinsonism. In:  Kryger M,  Roth T,  Dement WC editor. Principles and practice of sleep medicine. Philadelphia, PA: WB Saunders Co; 2000;p. 1051–1057
  6. El-Ad B, Korczyn AD. Disorders of excessive daytime sleepiness – an update. J Neurol Sci. 1998;153:192–202
  7. Larsen JP, Tandberg E. Sleep disorders in patients with Parkinson's disease: epidemiology and management. CNS Drugs. 2001;15:267–275
  8. van Hilten B, Hoff JI, Middelkoop HA, van der Velde EA, et al.  Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring. Arch Neurol. 1994;51:922–928
  9. Factor SA, McAlarney T, Sanchez-Ramos JR, Weiner WJ. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord. 1990;5:280–285
  10. Roth T, Roehrs T. Etiologies and sequelae of excessive daytime sleepiness. Clin Ther. 1996;8:562–576
  11. Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord. 1999;14:922–927
  12. Rye DB, Bliwise DL, Dihenia B, Gurecki P. FAST TRACK: daytime sleepiness in Parkinson's disease. J Sleep Res. 2000;9:63–69
  13. Arnulf I, Konofal E, Merino-Andreu M, Houeto JL, et al.  Parkinson's disease and sleepiness: an integral part of PD. Neurology. 2002;58:1019–1024
  14. Hobson DE, Lang AE, Martin WRW, Razmy A, et al.  Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease. A survey by the Canadian Movement Disorders Group. J Am Med Assoc. 2002;(287):455–463
  15. Parkinson Study Group. Safety and efficacy of pramipexole in early Parkinson disease. A randomized dose-ranging study. J Am Med Assoc. 1997;278:125–130
  16. Sethi KD, O'Brien CF, Hammerstad JP, Adler CH, et al.  For the Ropinirole Study Group. Ropinirole for the treatment of early Parkinson disease. Arch Neurol. 1998;55:1211–1216
  17. Frucht S, Rogers JD, Greene PF, Gordon MF, et al.  Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology. 1999;52:1908–1910
  18. Olanow CW, Schapira AHV, Roth T. Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole [letter]. Neurology. 2000;54:274
  19. Ferreira JJ, Galitzky M, Montastruc JL, Rascol O. Sleep attacks and Parkinson's disease treatment [letter]. Lancet. 2000;355:1333–1334
  20. Rye D, Johnston L, Watts R, Bliwise D. Juvenile Parkinson's disease with REM behavior disorder, sleepiness and daytime REM-onsets. Neurology. 1999;53:1868–1870
  21. Rye DB, Jankovic J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology. 2002;58:341–346
  22. Johns MW. Sleepiness in different situations measured by the Epworth Sleepiness Scale. Sleep. 1994;17:703–710
  23. van Ert PM, Gapinski JP, Fuller MJ, Stevenson JE. The predictive value of the Epworth Sleepiness Scale: patient vs. significant other assessment of patient sleepiness. Sleep Research. 1999;22(1):
  24. Carskadon M. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep. 1986;9:519–524
  25. Reynolds CF, Coble PA, Kupfer DJ, Holzer BC. Application of the multiple sleep latency test in disorders of excessive sleepiness. Electroenceph clin Neurophysiol. 1982;53:443–452
  26. Richardson GS, Carskadon MA, Flagg W, van den Hoed J, et al.  Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects. Electroenceph clin Neurophysiol. 1978;45:621–627
  27. Lavigne GJ, Manzini C. Bruxism. In:  Kryger M,  Roth T,  Dement WC editor. Principles and practice of sleep medicine. Philadelphia, PA: WB Saunders Co; 2000;p. 773–785
  28. Lowe AA. Oral appliances for sleep breathing disorders. In:  Kryger TM,  Roth T,  Dement WC editor. Principles and practice of sleep medicine. Philadelphia, PA: WB Saunders Co; 2000;p. 929–939
  29. Bliwise DL, Willians ML, Irbe D, Pour Ansari F, et al.  Inter-rater reliability for identification of REM sleep in Parkinson's disease. Sleep. 2000;23:671–676
  30. Wetter TC, Brunner H, Hogl B, Yassouridis A, et al.  Increased alpha activity in REM sleep in do novo patients with Parkinson's disease. Mov Disord. 2001;16:928–933
  31. Roehrs T, Zorick F, Sicklesteel J, Wittig R, et al.  Excessive daytime sleepiness associated with insufficient sleep. Sleep. 1983;6:319–325
  32. Gjerstad MD, Aarsland D, Larsen JP. Daytime somnolence over time in Parkinson's disease. Neurology. 2002;58:1544–1546
  33. Richardson JW, Fredrickson PA, Lin SC. Narcolepsy update. Mayo Clin Proc. 1990;65:991–998
  34. Hauser RA, Gauger L, Anderson WM, Zesiewicz TA. Pramipexole-induced somnolence and episodes of daytime sleep. Mov Disord. 2000;15:658–663
  35. Tracik F, Ebersbach G. Sudden daytime sleep onset in Parkinson's disease: polysomnographic recordings. Mov Disord. 2001;16:500–506
  36. Ferreira JJ, Galitzky M, Thalamas C, Tiberge M, et al.  Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers. Neurology. 2002;58:460–462

PII: S1389-9457(03)00058-3

doi: 10.1016/S1389-9457(03)00058-3

Sleep Medicine
Volume 4, Issue 4 , Pages 275-280 , July 2003

Article Tools